A Study to Assess How the Body Absorbs ABBV-8736 Subcutaneous Injections Relative to Intravenous Injections in Adult Healthy Volunteers
Study Identifier
M25-478
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 1
Sex
Female & Male
Age
18 - 60 Years
Protocol Summary
The purpose of this study is to assess the pharmacokinetics (PK), bioavailability, immunogenicity, safety, and tolerability of ABBV-8736 following subcutaneous (SC) administration relative to intravenous (IV) administration.
Study Locations
Location
Status
Location
CenExel ACT- Anaheim Clinical Trials /ID# 280481
Anaheim, California, United States, 92801
Status
Not applicable
Location
Acpru /Id# 280382
Grayslake, Illinois, United States, 60030
Status
Not applicable